Attached files

file filename
EX-99.1 - PRESS RELEASE - LIBERATOR MEDICAL HOLDINGS, INC.v347910_ex99-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 14, 2013

 

LIBERATOR MEDICAL HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

NEVADA 000-05663 87-0267292
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number)

 

2979 SE Gran Park Way, Stuart, Florida 34997

(Address of Principal Executive Offices)

 

(772) 287-2414

(Registrant’s telephone number, including area code)

 

 

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d)Exhibits

 

Exhibit No.Description

 

99.1Press release issued by Liberator Medical Holdings, Inc., on June 14, 2013.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  LIBERATOR MEDICAL HOLDINGS, INC.
  Registrant
   
   
Dated: June 17, 2013 /s/ Mark A. Libratore
  Mark A. Libratore, President